Recruitment And Diversity

1. Patient Trust In Pharma Is Low; Here's How To Rebuild It 2/2/2026

   CISCRP's Annick de Bruin and Shalome Sine provide strategies for building patient trust based on the findings from their Perceptions & Insights Study.

2. The U.S. Trial Advantage Is Eroding 1/30/2026

   Once the go-to location for trials, the U.S. is now seeing competition from APAC, driven by political, economic, and workforce pressures domestically and rapid growth abroad.

3. Will New AI Health Assistants Suggest Clinical Trials To Inquiring Patients? 1/27/2026

   New AI health assistants are now doing even more to help patients make sense of symptoms, diagnoses, and treatment options. What does that mean for the discoverability of clinical trials?

4. How Gilead Includes Patients Most Affected By HIV In Its PrEP Trials 1/26/2026

   VP of Clinical Development, HIV, Moupali Das shares how the sponsor approaches diverse participant recruitment and enrollment, highlighting the importance of early demographic research and careful, intentional PI selection.

5. "Study Within A Study" Reveals Best Recruitment Strategies For Alzheimer's Trials 1/20/2026

   In this Q&A, Acumen Pharmaceuticals shares findings from its Alzheimer's recruitment study, highlighting what efforts proved the most fruitful.

6. Endpoints, Procedures, And Deviations Are On The Rise — Why? 1/20/2026

   SCRS Chief Site Success Officer Jimmy Bechtel, MBA, and Tufts CSDD Executive Director Ken Getz, MBA, discuss why they're on the rise explore ways to address, and even accept, them. 

7. Confronting "Time Toxicity" In Global Oncology And Rare Disease Trials For Operational Excellence And Patient Retention 1/14/2026

   Time is the only truly finite resource in a clinical trial. Consultant Leila Cupersmith discusses how sponsors can better design trials with a lower time burden to boost enrollment, retention, and overall operational excellence.

8. Researchers Want A Design Shake-Up In 2026 1/7/2026

   When asked what clinical research professionals should leave behind in 2025, quite a few lamented the stale, even problematic, approach to clinical trial design. Here's what they want done differently in 2026.

9. The Site Perspective: Why Ambient AI Is The Missing Link In Clinical Trial Data Integrity 12/10/2025

   Discover how AI ambient listening has changed the way Mikel Daniels, DPM, MBA, and his team conduct clinical research at WeTreatFeet Podiatry. 

10. Designing Patient-Centric Recruitment Pathways With Real-Time Adherence Insights 12/8/2025

    Learn how digital adherence solutions can enable real-time monitoring and site-level oversight to improve patient engagement and protocol compliance.